It can be better assessed by non-radiomics models, using standard variables of interest: gender, tumor size, multinodularity, ALBI score, and AFP level, allowing one to distinguish three risk groups: low (20%), moderate (42%), or high risk (65%) [21]. The gene discussed is AFP; the disease is neoplasm.